Diaceutics plc (DXRX.L)
Diaceutics plc, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics plc was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Company Info
ISIN | GB00BJQTGV64 |
---|---|
Sector | Healthcare |
Industry | Diagnostics & Research |
Highlights
Market Cap | £84.26M |
---|---|
PE Ratio | 104.50 |
Revenue (TTM) | £21.90M |
Gross Profit (TTM) | £16.74M |
EBITDA (TTM) | £1.33M |
Year Range | £79.00 - £110.00 |
Target Price | £166.60 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in Diaceutics plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Diaceutics plc had a return of 12.64% year-to-date (YTD) and 0.00% in the last 12 months.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 12.64% | 7.50% |
1 month | -6.22% | -1.61% |
6 months | 13.95% | 17.65% |
1 year | 0.00% | 26.26% |
5 years (annualized) | 1.27% | 11.73% |
10 years (annualized) | N/A | 10.64% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 20.11% | -8.13% | 11.46% | -7.48% | ||||||||
2023 | -20.48% | 10.78% | -5.95% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of DXRX.L is 45, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Diaceutics plc(DXRX.L)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Diaceutics plc (DXRX.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Diaceutics plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Diaceutics plc was 60.27%, occurring on Nov 29, 2022. The portfolio has not yet recovered.
The current Diaceutics plc drawdown is 47.73%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-60.27% | Jul 30, 2020 | 589 | Nov 29, 2022 | — | — | — |
-34.15% | Feb 13, 2020 | 23 | Mar 16, 2020 | 76 | Jul 6, 2020 | 99 |
-18.36% | Apr 2, 2019 | 64 | Jul 4, 2019 | 133 | Jan 13, 2020 | 197 |
-4.85% | Mar 26, 2019 | 2 | Mar 27, 2019 | 1 | Mar 28, 2019 | 3 |
-3.82% | Jul 20, 2020 | 1 | Jul 20, 2020 | 2 | Jul 22, 2020 | 3 |
Volatility
Volatility Chart
The current Diaceutics plc volatility is 4.60%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |